{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T16:32:04Z","timestamp":1783960324717,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jad-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.jad.2016.09.053","type":"journal-article","created":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:15:18Z","timestamp":1475799318000},"page":"429-433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["L-Methylfolate For Bipolar I depressive episodes: An open trial proof-of-concept registry"],"prefix":"10.1016","volume":"207","author":[{"given":"Andrew A.","family":"Nierenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Montana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Kinrys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thilo","family":"Deckersbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Dufour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hyun","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2016.09.053_bib1","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/sj.ejcn.1602778","article-title":"The folic acid metabolite L-5-methyltetrahydrofolate effectively reduces total serum homocysteine level in orthotopic liver transplant recipients: a double-blind placebo-controlled study","volume":"62","author":"Akoglu","year":"2008","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.jad.2016.09.053_bib2","doi-asserted-by":"crossref","first-page":"807","DOI":"10.4088\/JCP.v63n0910","article-title":"Subsyndromal depression is associated with functional impairment in patients with bipolar disorder","volume":"63","author":"Altshuler","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2016.09.053_bib3","first-page":"321","article-title":"Quality of life enjoyment and satisfaction questionnaire","volume":"29","author":"Endicott","year":"1993","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.jad.2016.09.053_bib4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1017\/S1092852900003473","article-title":"The role of L-methylfolate in depressive disorders","volume":"14","author":"Farah","year":"2009","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jad.2016.09.053_bib5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000201934","article-title":"Reliability and validity of the Massachusetts general hospital cognitive and physical functioning questionnaire","volume":"78","author":"Fava","year":"2009","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.jad.2016.09.053_bib6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S2215-0366(15)00450-2","article-title":"Comparative evaluation of quetiapine plus lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in bipolar depression (CEQUEL): a 2\u00d72 factorial randomised trial","volume":"3","author":"Geddes","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jad.2016.09.053_bib7","first-page":"19","article-title":"L-methylfolate Plus SSRI or SNRI from Treatment Initiation Compared to SSRI or SNRI Monotherapy in a Major Depressive Episode","volume":"8","author":"Ginsberg","year":"2011","journal-title":"Innov. Clin. Neurosci."},{"key":"10.1016\/j.jad.2016.09.053_bib8","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/0140-6736(90)91942-4","article-title":"Enhancement of recovery from psychiatric illness by methylfolate","volume":"336","author":"Godfrey","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2016.09.053_bib9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF02289823","article-title":"On methods in the analysis of profile data","volume":"24","author":"Greenhouse","year":"1959","journal-title":"Psychometrika"},{"key":"10.1016\/j.jad.2016.09.053_bib10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/10401239309148970","article-title":"An open trial of methyltetrahydrofolate in elderly depressed patients","volume":"5","author":"Guaraldi","year":"1993","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2016.09.053_bib11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1046\/j.1399-5618.2003.00091.x","article-title":"A prospective, longitudinal study of percentage of time spent ill in patients with bipolar I or bipolar II disorders","volume":"6","author":"Joffe","year":"2004","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2016.09.053_bib12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0165-0327(02)00332-4","article-title":"The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases","volume":"73","author":"Judd","year":"2003","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2016.09.053_bib13","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archpsyc.59.6.530","article-title":"The long-term natural history of the weekly symptomatic status of bipolar I disorder","volume":"59","author":"Judd","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2016.09.053_bib14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0387-7604(02)00163-8","article-title":"Effects of valproate and carbamazepine on serum levels of homocysteine, vitamin B12, and folic acid","volume":"25","author":"Karabiber","year":"2003","journal-title":"Brain Dev."},{"key":"10.1016\/j.jad.2016.09.053_bib15","article-title":"Definition and etiology","author":"Khalife","year":"2010","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2016.09.053_bib16","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1399-5618.2004.00158.x","article-title":"Demographic and diagtic characteristics of the first 1000 patients enrolled in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)","volume":"6","author":"Kogan","year":"2004","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2016.09.053_bib17","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0924-9338(97)83296-8","article-title":"The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI","volume":"12","author":"Lecrubier","year":"1997","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.jad.2016.09.053_bib18","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1017\/S0033291799008570","article-title":"The Range of Impaired Functioning Tool (LIFE\u2013RIFT): a brief measure of functional impairment","volume":"29","author":"Leon","year":"1999","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2016.09.053_bib19","first-page":"343","article-title":"SAFTEE: a technique for the systematic assessment of side effects in clinical trials","volume":"22","author":"Levine","year":"1986","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.jad.2016.09.053_bib20","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0364-7722(79)90058-4","article-title":"Depressive symptoms in acute schizophrenia","volume":"3","author":"Montgomery","year":"1979","journal-title":"Prog. Neuro-Psychopharmacol."},{"key":"10.1016\/j.jad.2016.09.053_bib21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4088\/PCC.9064su1c.04","article-title":"A critical appraisal of treatments for bipolar disorder","volume":"12","author":"Nierenberg","year":"2010","journal-title":"Prim. Care Companion J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2016.09.053_bib22","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1176\/appi.ajp.2012.12060751","article-title":"Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium","volume":"170","author":"Nierenberg","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2016.09.053_bib23","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/1740774513512184","article-title":"Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder (Bipolar CHOICE): a pragmatic trial of complex treatment for a complex disorder","volume":"11","author":"Nierenberg","year":"2014","journal-title":"Clin. Trials"},{"key":"10.1016\/j.jad.2016.09.053_bib24","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1176\/appi.ajp.2013.13020185","article-title":"The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders","volume":"170","author":"Pacchiarotti","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2016.09.053_bib25","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1176\/appi.ajp.2012.11071114","article-title":"L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials","volume":"169","author":"Papakostas","year":"2012","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2016.09.053_bib26","first-page":"63","article-title":"Oral 5\u2032-methyltetrahydrofolic acid in senile organic mental disorders with depression: results of a double-blind multicenter study","volume":"5","author":"Passeri","year":"1993","journal-title":"Aging (Milano)"},{"key":"10.1016\/j.jad.2016.09.053_bib27","doi-asserted-by":"crossref","first-page":"680","DOI":"10.4088\/JCP.v64n0610","article-title":"Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method","volume":"64","author":"Post","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2016.09.053_bib28","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0006-3223(02)01866-8","article-title":"The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression","volume":"54","author":"Rush","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2016.09.053_bib29","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0140-6736(81)90650-4","article-title":"The methyl folate trap: a physiological response in man to prevent methyl group deficiency in kwashiorkor (methionine deficiency) and an explanation for folic-acid-induced exacerbation of subacute combined degeneration in pernicious anaemia","volume":"318","author":"Scott","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2016.09.053_bib30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0165-1781(97)00123-6","article-title":"Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP","volume":"73","author":"Spearing","year":"1997","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2016.09.053_bib31","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1017\/S1092852900015418","article-title":"Novel therapeutics for depression: L-methylfolate as a trimonoamine modulator and antidepressant-augmenting agent","volume":"12","author":"Stahl","year":"2007","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jad.2016.09.053_bib32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0920-1211(00)00101-7","article-title":"Homocysteine, folate, vitamin B-12 and vitamin B-6 in patients receiving antiepileptic drug monotherapy","volume":"40","author":"Tamura","year":"2000","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.jad.2016.09.053_bib33","doi-asserted-by":"crossref","first-page":"757","DOI":"10.4088\/JCP.11m06837","article-title":"Concise Health Risk Tracking scale: a brief self-report and clinician rating of suicidal risk","volume":"72","author":"Trivedi","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2016.09.053_bib34","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1093\/jn\/132.9.2737","article-title":"Acute valproate administration impairs methionine metabolism in rats","volume":"132","author":"\u00dabeda","year":"2002","journal-title":"J. Nutr."},{"key":"10.1016\/j.jad.2016.09.053_bib35","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0920-1211(00)00150-9","article-title":"Hyperhomocysteinemia in children treated with sodium valproate and carbamazepine","volume":"41","author":"Verrotti","year":"2000","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.jad.2016.09.053_bib36","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/sj.bjp.0705446","article-title":"Pharmacokinetic study on the utilisation of 5\u2013methyltetrahydrofolate and folic acid in patients with coronary artery disease","volume":"141","author":"Willems","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jad.2016.09.053_bib37","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br. J. Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032716306048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032716306048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T10:02:33Z","timestamp":1568455353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032716306048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":37,"alternative-id":["S0165032716306048"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2016.09.053","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"L-Methylfolate For Bipolar I depressive episodes: An open trial proof-of-concept registry","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2016.09.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}